French authorise embryonic stem cell lines:
This article was originally published in Clinica
The development of new diagnostics and medicines are two of the reasons cited by the French Research Minister, Roger-Gerard Schwartzenberg, for authorising the import of two embryonic stem cell lines on May 3, three days before the government stepped down following the re-election of President Jacques Chirac. His successor will have to confirm or revoke the authorisation, which was made after the lower house of parliament agreed on the principle of research on such cells when it passed the bioethics bill. The bill is unlikely to become law until 2003, but the ready availability to French researchers of the stem cell lines is intended to help speed matters.
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.